Veeva Systems Inc. (VEEV): Price and Financial Metrics


Veeva Systems Inc. (VEEV)

Today's Latest Price: $291.80 USD

3.03 (-1.03%)

Updated Oct 22 1:12pm

Add VEEV to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 70 in Medical - Services

See all "A" rated Strong Buy stocks

VEEV Stock Summary

  • VEEV has a higher market value than 95.48% of US stocks; more precisely, its current market capitalization is $44,468,151,050.
  • VEEV's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 902.76 -- higher than 96.27% of US-listed equities with positive expected earnings growth.
  • The price/operating cash flow metric for Veeva Systems Inc is higher than 96.07% of stocks in our set with a positive cash flow.
  • Stocks that are quantitatively similar to VEEV, based on their financial statements, market capitalization, and price volatility, are SEDG, NVCR, MPWR, QLYS, and RNG.
  • Visit VEEV's SEC page to see the company's official filings. To visit the company's web site, go to www.veeva.com.

VEEV Stock Price Chart Interactive Chart >

Price chart for VEEV

VEEV Price/Volume Stats

Current price $291.80 52-week high $313.99
Prev. close $294.83 52-week low $118.11
Day low $286.95 Volume 364,447
Day high $297.85 Avg. volume 1,223,267
50-day MA $278.58 Dividend yield N/A
200-day MA $212.25 Market Cap 44.01B

Veeva Systems Inc. (VEEV) Company Bio


Veeva Systems provides cloud-based software solutions for the life sciences industry in North America, Europe, the Asia Pacific, and Latin America. The company was founded in 2007 and is based in Pleasanton, California.


VEEV Latest News Stream


Event/Time News Detail
Loading, please wait...

VEEV Latest Social Stream


Loading social stream, please wait...

View Full VEEV Social Stream

Latest VEEV News From Around the Web

Below are the latest news stories about Veeva Systems Inc that investors may wish to consider to help them evaluate VEEV as an investment opportunity.

Cloud Stocks: The Unstoppable Veeva

According to a Markets and Markets report, the global market for healthcare cloud computing is expected to grow from $28.1 billion in 2020 to $64.7 billion by 2025 at a CAGR of 18.1%. Pleasanton, California-based Veeva (VEEV) recently reported its second-quarter results that continued to surpass all market expectations. Veeva's...

Sramana Mitra on Seeking Alpha | October 1, 2020

Global eClinical Solutions Market 2020-2026 Refreshing Trends || Major Giants – Oracle, Medidata Solutions, Inc., Veeva Systems, ERT Clinical, eClinical Solutions LLC, IBM Corporation

DBMR has added a new report titled Global eClinical Solutions Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. The data and the information regarding the industry are taken from

OpenPR | September 30, 2020

Veeva Systems: Strong Healthcare CRM Play, But Valuation Is Full

Investment Thesis Veeva Systems (VEEV) is a leading vertical SaaS play focused on providing a core CRM product alongside other life science-focused software tools to a largely pharmaceutical and biotechnology company customer base. The stock has performed well, particularly vs. the S&P, as illustrated below: Data by YCharts The life...

Captain Alpha on Seeking Alpha | September 29, 2020

Veeva partners with RedHill Bio to advance Opaganib in COVID-19 (NASDAQ:RDHL)

Veeva Systems (NYSE:VEEV) and Bioforum collaborates with RedHill Biopharma (NASDAQ:RDHL) on a global Phase 2/3 clinical study evaluating opaganib (Yeliva,

Seeking Alpha | September 23, 2020

Worldwide Risk-based Monitoring Software Industry to 2026 - Featuring MasterControl, Veeva Systems & Techso Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Risk-based Monitoring Software Market Analysis 2020" report has been added to ResearchAndMarkets.com's offering. The Global Risk-based Monitoring Software market is expected to reach $652.40 million by 2026 growing at a CAGR of 15.3% from 2019 to 2026. Risk-based monitoring (RBM) software is a clinical trial-monitoring method that fulfills regulatory necessities. It employs various tools, platforms and dashboards to identify signals, which indicate potential

Business Wire | September 18, 2020

Read More 'VEEV' Stories Here

VEEV Price Returns

1-mo 6.71%
3-mo 15.82%
6-mo 55.52%
1-year 105.10%
3-year 384.15%
5-year 1,054.27%
YTD 107.45%
2019 57.48%
2018 61.58%
2017 35.82%
2016 41.07%
2015 9.24%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7352 seconds.